Startup profile · funding coverage
Boltz
MIT-founded biotech applying open AI protein models to lab deployment (public-benefit corp).
Stage
seed
Status
private
Coverage
full
Why Boltz is interesting
Markforged-alumni-adjacent hard-tech bet on accessible structural biology models — large seed syndicate despite name collision with Bitcoin infra.
Key facts
- Seed (Dec 2025): $28M led by Zetta and Amplify with a16z participation — MIT biotech Boltz (public reporting)
- Note: distinct from self-funded Bitcoin Lightning exchange Boltz Exchange
- Co-investors not in VCT directory: Zetta Venture Partners, Amplify Partners, Obvious Ventures, Factorial Capital
- Source: https://nordic9.com/news/boltz-secured-28-million-in-a-seed-funding-round-led-by-zetta-amplify-and-a16z-joined-by-factorial-capital-obvious-ventures-and-angel-investors/
- VCT directory co-investors: none mapped (non-directory syndicates noted above); reviewed 2026-07-24
Investors in our directory
Funds linked from Boltz's profile — open a fund page for stage focus and related deal articles.
Industries
Generalist Technology
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Related funding articles
Venture Capital Tracker pieces that cover Boltz's financing or category context.
Last updated: 2026-07-24